Old Web
English
Sign In
Acemap
>
authorDetail
>
Donald Harder
Donald Harder
Eli Lilly and Company
Psychology
Psychiatry
Clinical psychology
Placebo
Atomoxetine
4
Papers
738
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Parent Rating of Offspring Behavior
2020
David Mickelson
Albert J. Allen
Joan Busner
Charles D. Casat
David W. Dunn
Christopher J. Kratochvil
Jeffrey H. Newcorn
F. Randy Sallee
R. Bart Sangal
Keith E. Saylor
Scott A. West
Douglas Kelsey
Joachim F. Wernicke
Nancy J. Trapp
Donald Harder
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
2004
Journal of Attention Disorders
S. Kaplan
John H. Heiligenstein
Scott A. West
J. Busner
Donald Harder
Ralf W. Dittmann
Charles D. Casat
Joachim Wernicke
Show All
Source
Cite
Save
Citations (59)
Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study
2002
American Journal of Psychiatry
David Michelson
Albert J. Allen
Joan Busner
Charles D. Casat
David W. Dunn
Christopher J. Kratochvil
Jeffrey H. Newcorn
F. Randy Sallee
R. Bart Sangal
Keith E. Saylor
Scott West
Douglas Kelsey
Joachim Wernicke
Nancy J. Trapp
Donald Harder
Show All
Source
Cite
Save
Citations (525)
Validation of the ADHD Rating Scale as a clirlician administered and scored instrument
2001
Journal of Attention Disorders
Douglas E. Faries
Ilker Yalcin
Donald Harder
John H. Heiligenstein
Show All
Source
Cite
Save
Citations (154)
1